Werfen Aptiva APS IgA Reagent Cleared by FDA and CE Marked

Werfen's Aptiva APS IgA Reagent has received FDA 510(k) clearance and CE marking, completing its antiphospholipid syndrome testing portfolio for all three Ig isotypes on its automated Aptiva platform, enhancing autoimmune diagnostic options.

This Wire brief sits within Fusion42's coverage of Medtech.